The SF Standard reports that a San Francisco man whose car was stolen in the middle of the night "managed to track down the vehicle using his car insurance app and retrieve the stolen vehicle the following morning within half an hour of noticing it was gone." Harris realized he could track his phone using his app from MetroMile, a San Francisco-based digital pay-per-mile car insurance company that tracks a car's location and charges a rate based on how much it's driven. "I opened the app and found it was in Mission Bay," he said, adding that the person who stole it drove it all night before parking. "I rode my bike down there and picked it up...."

Before picking up his car, Harris didn't consult with the San Francisco Police Department and said officers were confused about why he wanted to report a stolen car that was already back in his possession. He said his driver's side window had been smashed, but there wasn't any other damage, just a mess of marijuana paraphernalia and blunt wraps inside... "If a vehicle owner locates their stolen vehicle prior to the police locating it, we highly recommend that they alert us to the vehicle's location and do not move the car prior to reporting it recovered," Sgt. Kathryn Winters wrote in an email. "Additionally, if they locate the vehicle occupied, they should not approach the vehicle or suspects and should call law enforcement immediately."

There were 274 motor vehicle theft reports in the Western Addition neighborhood, which includes Alamo Square, in the 12 months leading up to Oct. 21 compared with 219 during the same period the previous year, according to police data. Citywide, the problem has also gotten worse in recent years. The number of car thefts has risen from 60 incidents per 10,000 residents in 2019 to 101 incidents this year.

An anonymous reader shares a report: On May 4, 2022, NASA's InSight lander detected the largest quake yet recorded on Mars, one with a 4.7 magnitude -- fairly modest by Earth standards but strong for our planetary neighbor. Given Mars lacks the geological process called plate tectonics that generates earthquakes on our planet, scientists suspected a meteorite impact had caused this marsquake. But a search for an impact crater came up empty, leading scientists to conclude that this quake was caused by tectonic activity -- rumbling in the planet's interior -- and giving them a deeper understanding about what makes Mars shake, rattle and roll.

"We concluded that the largest marsquake seen by InSight was tectonic, not an impact. This is important as it shows the faults on Mars can host hefty marsquakes," said planetary scientist Ben Fernando of the University of Oxford in England, lead author of the research published this week in the journal Geophysical Research Letters. "We really thought that this event might be an impact." "This represents a significant step forward in our understanding of Martian seismic activity and takes us one step closer to better unraveling the planet's tectonic processes," added Imperial College London planetary scientist and study co-author Constantinos Charalambous, co-chair of InSight's Geology Working Group.

NASA retired InSight in 2022 after four years of operations. In all, InSight's seismometer instrument detected 1,319 marsquakes. Earth's crust - its outermost layer - is divided into immense plates that continually shift, triggering quakes. The Martian crust is a single solid plate. But that does not mean all is quiet on the Martian front. "There are still faults that are active on Mars. The planet is still slowly shrinking and cooling, and there is still motion within the crust even though there are no active plate tectonic processes going on anymore. These faults can trigger quakes," Fernando said.

AMD on Monday completed the acquisition of Xilinx, creating a company that can offer various types of compute devices, including CPUs, GPUs, and FPGAs. Tom's Hardware reports: AMD CEO Dr. Lisa Su told analyst Patrick Moorhead that the first processor combining Xilinx technologies will arrive in 2023, which is in contrast to the company's previous integration efforts. After AMD bought ATI Technologies in 2006, it took the company five years to build its first accelerated processing units (which included AMD's x86 cores and ATI's GPU). This time AMD inked a long-term development pact with Xilinx and was able to work collaboratively even before the regulators approved the transaction. It remains to be seen what exactly AMD plans to offer, but it is reasonable to expect the new processor to feature AMD's x86 cores and Xilinx's programmable engines.

The move will help AMD to continue expanding its presence in the datacenter sector and offer unique solutions that will combine IP ingredients designed by the two companies. Interestingly, the first fruits of the deal are expected to materialize next year. [...] The Xilinx business will become AMD's Adaptive and Embedded Computing Group (AECG), led by former Xilinx CEO Victor Peng. As a result, Xilinx will maintain its leadership for at least a while. Furthermore, AMD's embedded business will cease to be a part of the company's enterprise and semi-custom unit and will merge into AECG, which might be good news as executives from the enterprise division will now spend more time on EPYC CPUs. "The acquisition of Xilinx brings together a highly complementary set of products, customers and markets combined with differentiated IP and world-class talent to create the industry's high-performance and adaptive computing leader," said Lisa Su, chief executive of AMD. "Xilinx offers industry-leading FPGAs, adaptive SoCs, AI inference engines and software expertise that enable AMD to offer the strongest portfolio of high-performance and adaptive computing solutions in the industry and capture a larger share of the approximately $135 billion market opportunity we see across cloud, edge, and intelligent devices."

Tencent has announced plans to buy British video game company Sumo Group for $1.27 billion. The Verge reports: The Chinese tech giant already has an 8.75-percent stake in the developer, as Gamesindustry.biz reports, and the offer represents a 43-percent premium on Sumo's current valuation. Based in Sheffield, England, Sumo's well-regarded core studio Sumo Digital has carried out contract work for many of the biggest names in gaming. It developed Sony's PlayStation 5 launch title Sackboy: A Big Adventure and was the primary studio behind Microsoft's Crackdown 3 for Xbox consoles and PC. In 2017 Sumo released Snake Pass for multiple platforms, its first foray into original IP.

"The three founders of Sumo, who work in the business, Paul Porter, Darren Mills and I are passionate about what we do and are fully committed to continuing in our roles," says Sumo CEO Carl Cavers in a statement. "The opportunity to work with Tencent is one we just couldn't miss. It would bring another dimension to Sumo, presenting opportunities for us to truly stamp our mark on this amazing industry, in ways which have previously been out-of-reach." Cavers says Tencent has "demonstrated its commitment to backingâ Sumo's client work, as well as its own original IP, so things are unlikely to change too quickly. The buyout does, however, give Tencent yet another foothold in the international gaming industry, following prominent investments in companies like Epic, Riot, Activision, and Ubisoft. "Tencent intends to bring its expertise and resources to accelerate the growth of Sumo both in the UK and abroad, supporting Sumo in the market for top-notch creative talent, and the UK as a hub for game innovation," says Tencent's chief strategy officer James Mitchell. "We believe the proposed transaction benefits all stakeholders, delivers compelling value for Sumo shareholders, while enhancing the Sumo business for the future."

sciencehabit shares a report from Science Magazine: When Chris Mason's daughter was a toddler, he watched, intrigued, as she touched surfaces on the New York City subway. Then, one day, she licked a pole. "There was a clear microbial exchange," says Mason, a geneticist at Weill Cornell Medicine. "I desperately wanted to know what had happened." So he started swabbing the subway, sampling the microbial world that coexists with people in our transit systems. After his 2015 study revealed a wealth of previously unknown species in New York City, other researchers contacted him to contribute. Now, Mason and dozens of collaborators have released their study of subways, buses, elevated trains, and trams in 60 cities worldwide, from Baltimore to Bogota, Colombia, to Seoul, South Korea. They identified thousands of new viruses and bacteria, and found that each city has a unique microbial "fingerprint."

They found that about 45% didn't match any known species: Nearly 11,000 viruses and 1,302 bacteria were new to science. The researchers also found a set of 31 species present in 97% of the samples; these formed what they called a "core" urban microbiome. A further 1145 species were present in more than 70% of samples. Samples taken from surfaces that people touch -- like railings -- were more likely to have bacteria associated with human skin, compared with surfaces like windows. Other common species in the mix were bacteria often found in soil, water, air, and dust. But the researchers also found species that were less widespread. Those gave each city a unique microbiomeâ"and helped the researchers predict, with 88% accuracy, which city random samples came from, they report today in Cell.

The study's main value isn't in its findings (which are mapped here) so much as its open data, available at metagraph.ethz.ch, says Noah Fierer, a microbiologist at the University of Colorado, Boulder, who was not involved with the research. That will give other researchers the chance to delve into new questions. "Different cities have different microbial communities," Fierer says. "That's not super surprising. The question for me is, why?" Mason sees an opportunity for "awe and excitement about mass transit systems as a source of unexplored and phenomenal biodiversity." Newly discovered species have potential for drug research, he says, and wide-scale mapping and monitoring of urban microbiomes would be a boon for public health, helping researchers spot emerging pathogens early.

BBVA today told users of Simple -- the pioneering mobile and online banking app that it acquired for $117 million in 2014 -- that it is planning to shut down the service, moving accounts to BBVA's USA business in the process. TechCrunch reports: The move is part of an ongoing effort at BBVA -- which had been an active investor and acquirer of startups -- to streamline its business as it works on closing a merger with PNC. The latter bank announced in November last year that it would acquire the U.S. business of BBVA for $11.6 billion. In a note Simple sent out earlier today to users -- being shared on Twitter by a number of them -- the bank said that it will be transitioning their accounts to be serviced by BBVA USA, which already housed the accounts.

"BBVA USA has made the strategic decision to close Simple," the note reads. "There is no immediate impact to your accounts at Simple and nothing you need to do at this time. Since your deposits are already housed at BBVA USA, they will remain in FDIC-insured accounts there, up to the applicable limits. In the future, your Simple account will become exclusively serviced by BBVA USA, but until then you can continue to access your account and your money through the Simple app or online at Simple.com. Users will receive more details in the future about the transition to BBVA, the note continued. It is unclear how many users Simple has currently. It had around 100,000 users when it was acquired back in 2014, and some might say that the startup was ahead of its time.

Ben Bova "was the author of more than 120 works of science fact and fiction," according to Wikipedia, and was also a six-time winner of the Hugo Award. "He was also president of both the National Space Society and the Science Fiction Writers of America."

Tor.com reports Bova has passed "due to complications from COVID-19 and a stroke..." Born in 1932, Bova brought experience to the science fiction genre that few authors could match: he worked as a technical editor for the U.S.'s Project Vanguard, the first effort on the part of the country to launch a satellite into space in 1958. Bova went on to work as a science writer for Avco Everett Research Laboratory, which built the heat shields for the Apollo 11 module, putting man on the Moon and ensuring that science fiction would continue to increasingly define the future.

It was around that time that Bova began writing and publishing science fiction. He published his first novel, The Star Conquerors, in 1959, and followed up with dozens of others in the following years, as well as numerous short stories that appeared in publications such as Amazing Stories, Analog Science Fact and Fiction, Galaxy Magazine, The Magazine of Fantasy and Science Fiction, and others. In 1971, he took over the helm of Analog following the death of its long-running editor, John W. Campbell Jr. — a huge task, given Campbell's influence on the genre to that point... From there, he became the first editor of Omni Magazine until 1982, and consulted on television shows such as The Starlost and Land of the Lost.

While Bova wrote an episode of The Land of the Lost, his best-known works "involved plausible sciences about humanity's expansion into the universe, looking at how we might adapt to live in space..." notes Tor.

The Encyclopedia of Science Fiction argues that "the straightforwardness of Bova's agenda for humanity may mark him as a figure from an earlier era; but the arguments he laces into sometimes overloaded storylines are arguments it is important, perhaps absolutely vital, to make."

The Food and Drug Administration on Thursday approved Gilead Sciences' antiviral drug remdesivir as a treatment for the coronavirus. From a report: In May, the FDA granted the drug an emergency use authorization, allowing hospitals and doctors to use the drug on patients hospitalized with the disease even though the drug has not been formally approved by the agency. The intravenous drug has helped shorten the recovery time of some hospitalized Covid-19 patients. It was one of the drugs used to treat President Donald Trump, who tested positive for the virus earlier this month. Earlier in the year, Dr. Anthony Fauci, the nation's leading infectious disease expert, said the drug would set "a new standard of care" for Covid-19 patients. The drug will be used for Covid-19 patients requiring hospitalization, Gilead said. Remdesivir is now the first and only fully approved treatment in the U.S. for Covid-19, which has infected more than 41.3 million and killed more than 1 million, according to data compiled by Johns Hopkins University.